Humacyte Ownership | Who Owns Humacyte?
Humacyte Ownership Summary
Humacyte is owned by 36.63% institutional investors, 19.74% insiders, and 43.62% retail investors. Blackrock is the largest institutional shareholder, holding 6.60% of HUMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.42% of its assets in Humacyte shares.
HUMA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Humacyte | 36.63% | 19.74% | 43.62% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 7.14M | 6.60% | $34.27M |
Blackrock funding, inc. /de | 9.95M | 6.40% | $20.79M |
Vanguard group | 5.60M | 4.69% | $28.29M |
State street | 4.61M | 3.86% | $23.28M |
Woodline partners lp | 2.85M | 2.39% | $14.39M |
Geode capital management | 2.14M | 1.79% | $10.79M |
Marshall wace, llp | 2.64M | 1.70% | $5.52M |
Centerbook partners lp | 1.28M | 1.07% | $6.46M |
Ubs group | 1.12M | 0.94% | $5.66M |
Two sigma investments, lp | 919.10K | 0.77% | $4.64M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Centerbook partners lp | 1.28M | 0.39% | $6.46M |
Lji wealth management | 185.00K | 0.18% | $934.25K |
Endowment wealth management | 109.46K | 0.10% | $192.05K |
Woodline partners lp | 2.85M | 0.10% | $14.39M |
Wealth effects | 102.17K | 0.08% | $213.53K |
Gsa capital partners llp | 147.44K | 0.06% | $745.00K |
Clough capital partners l p | 240.93K | 0.05% | $504.00K |
Clarus wealth advisors | 39.97K | 0.05% | $102.72K |
Lasalle st. investment advisors | 60.49K | 0.03% | $126.00K |
Hamilton lane advisors | 21.89K | 0.03% | $45.76K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Marshall wace, llp | 2.64M | 0.01% | 2.59M |
Blackrock | 7.14M | 0.00% | 2.35M |
Woodline partners lp | 2.85M | 0.10% | 2.00M |
Blackrock funding, inc. /de | 9.95M | 0.00% | 1.72M |
Centerbook partners lp | 1.28M | 0.39% | 1.28M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Heights capital management | - | - | -4.03M |
Ra capital management | - | - | -3.31M |
Aigh capital management | - | - | -2.16M |
Toronto dominion bank | - | - | -2.13M |
Monashee investment management | - | - | -2.00M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Centerbook partners lp | 1.28M | 0.39% | 1.28M | $6.46M |
Franklin resources | 433.48K | 0.00% | 433.48K | $2.19M |
Lji wealth management | 185.00K | 0.18% | 185.00K | $934.25K |
Ieq capital | 91.90K | 0.00% | 91.90K | $192.06K |
Thompson siegel & walmsley | 35.00K | 0.00% | 35.00K | $177.00K |
Sold Out
Holder | Change |
---|---|
Org partners | -10.00 |
Russell investments group | -35.00 |
Gen-wealth partners | -85.00 |
Bare financial services | -104.00 |
Gamma investing | -112.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 163 | -6.86% | 56,940,940 | -6.40% | 36 | 1.71% | 104 | 8.33% | 26 | -29.73% |
Mar 31, 2025 | 176 | 2.92% | 61,024,544 | 45.00% | 46 | 3.74% | 97 | - | 37 | -7.50% |
Dec 31, 2024 | 87 | -42.38% | 22,175,982 | -38.04% | 18 | 2.07% | 52 | -41.57% | 18 | -30.77% |
Sep 30, 2024 | 149 | 14.62% | 35,789,080 | 14.71% | 29 | 3.61% | 90 | -8.16% | 25 | 78.57% |
Jun 30, 2024 | 129 | 27.72% | 31,200,461 | 33.99% | 28 | 5.69% | 97 | 110.87% | 14 | -58.82% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 3.78M | 2.42% | -33.25K |
iShares Russell 2000 ETF | 2.92M | 1.89% | -55.55K |
SPDR® S&P Biotech ETF | 2.24M | 1.45% | 55.44K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.28M | 0.82% | -561.50K |
Nuveen Quant Small Cap Equity R6 | 728.27K | 0.61% | - |
Fidelity Small Cap Index | 919.67K | 0.59% | -9.47K |
iShares Russell 2000 Value ETF | 827.91K | 0.53% | 614.00 |
iShares Biotechnology ETF | 765.10K | 0.49% | 6.54K |
MEDICAL BioHealth EUR Acc | 718.45K | 0.46% | - |
Fidelity Extended Market Index | 626.88K | 0.40% | 99.91K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 18, 2025 | Dougan Brady W | - | Sell | $1.01M |
Aug 20, 2025 | Dougan Brady W | - | Sell | $934.86K |
Aug 19, 2025 | Dougan Brady W | - | Sell | $1.79M |
Aug 19, 2025 | Niklason Laura E | President, CEO and Director | Sell | $1.79M |
Aug 18, 2025 | Niklason Laura E | President, CEO and Director | Sell | $1.01M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 6 |
2025 Q2 | 6 | - |
2025 Q1 | - | - |
2024 Q4 | 3 | 6 |
2024 Q3 | 3 | 13 |
HUMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools